SEATTLE, March 05, 2024 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that […]
Repurchasing approximately $110 million of 0% coupon, convertible senior notes at approximately 22% discount to par value Reduces remaining balance […]